» Articles » PMID: 9434102

Elevated Reactive Oxygen Species and Antioxidant Enzyme Activities in Animal and Cellular Models of Parkinson's Disease

Overview
Specialties Biochemistry
Biophysics
Date 1998 Jan 20
PMID 9434102
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

The dopaminergic neurotoxin N-methyl,4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) causes a syndrome in primates and humans which mimics Parkinson's disease (PD) in clinical, pathological, and biochemical findings, including diminished activity of complex I in the mitochondrial electron transport chain. Reduced complex I activity is found in sporadic PD and can be transferred through mitochondrial DNA, suggesting a mitochondrial genetic etiology. We now show that MPTP treatment of mice and N-methylpyridinium (MPP+) exposure of human SH-SY5Y neuroblastoma cells increases oxygen free radical production and antioxidant enzyme activities. Cybrid cells created by transfer of PD mitochondria exhibit similar characteristics; however, PD cybrids' antioxidant enzyme activities are not further increased by MPP+ exposure, as are the activities in control cybrids. PD mitochondrial cybrids are subject to metabolic and oxidative stresses similar to MPTP parkinsonism and provide a model to determine mechanisms of oxidative damage and cell death in PD.

Citing Articles

Evidence of compensation for mitochondrial reactive oxygen species increase in cytoplasmic-nuclear hybrids.

Hernandez E, Ross J, Dejean L MicroPubl Biol. 2024; 2024.

PMID: 39381639 PMC: 11459262. DOI: 10.17912/micropub.biology.001319.


Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease.

Kolacheva A, Pavlova E, Bannikova A, Bogdanov V, Ugrumov M Int J Mol Sci. 2024; 25(2).

PMID: 38279354 PMC: 10816442. DOI: 10.3390/ijms25021354.


Antioxidative Activities of Micronized Solid-State Cultivated Rich in Erinacine A against MPTP-Induced Damages.

Hsu C, Liao E, Chiang W, Wang K Molecules. 2023; 28(8).

PMID: 37110620 PMC: 10145912. DOI: 10.3390/molecules28083386.


Identification of minimum essential therapeutic mixtures from cannabis plant extracts by screening in cell and animal models of Parkinson's disease.

Morash M, Nixon J, Shimoda L, Turner H, Stokes A, Small-Howard A Front Pharmacol. 2022; 13():907579.

PMID: 36278152 PMC: 9586206. DOI: 10.3389/fphar.2022.907579.


The Role of Bioenergetics in Neurodegeneration.

Strope T, Birky C, Wilkins H Int J Mol Sci. 2022; 23(16).

PMID: 36012480 PMC: 9409169. DOI: 10.3390/ijms23169212.